Form 4 for ARQT Arcutis Biotherapeutics, Inc.

Accepted 2025-06-12 00:00:00 ET · period of report 2025-06-10 · accession 0002065881-25-000013 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2025-06-12	2025-06-10	ARQT	Watanabe Todd Franklin	See Remarks, Dir	G - Gift	$0.00	+1,994	25.4K	+9%	$0
M	2025-06-12	2025-06-10	ARQT	Watanabe Todd Franklin	See Remarks, Dir	G - Gift	$0.00	-1,994	913.1K	-0.2%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-06-10	G	A	997	$0.00	25,410	I By Trust	—	—	(F3) The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of these securities for purposes of Section 16 or for any other purposes. (F4) The securities are held of record by The Anderson Prest Watanabe Irrevocable Trust, of which the Reporting Person is the trustee.
2	Common	Common Stock	2025-06-10	G	D	997	$0.00	914,113	D By Trust	—	—	(F1) Includes 1,315 shares purchased under Arcutis Biotherapeutics, Inc. Employee Stock Purchase Plan on May 31, 2025. (F3) The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of these securities for purposes of Section 16 or for any other purposes. (F2) The securities are held of record by The John Franklin Watanabe Irrevocable Trust, of which the Reporting Person is the trustee.
3	Common	Common Stock	2025-06-10	G	A	997	$0.00	25,410	I	—	—
4	Common	Common Stock	2025-06-10	G	D	997	$0.00	913,116	D	—	—